Repurposing triamterene to target CLIC1 in glioblastoma stem cells: A new opportunity for an old drug?
Molecular Therapy · 2026-10 · 34 (10) · 5643-5645
DOI: 10.1016/j.ymthe.2026.09.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2026-10. Verfasst von Shubha Gururaja Rao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical & Biomedical Science, Raabe College of Pharmacy, Ohio Northern University, Ada, OH, USA. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Heart Lung and Blood Institute, American Heart Association Inc, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Pharmaceutical & Biomedical Science, Raabe College of Pharmacy, Ohio Northern University, Ada, OH, USA.
- Biophysics Graduate Program, The Ohio State University, Columbus, OH, USA; Department of Physiology and Cell Biology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
- Biophysics Graduate Program, The Ohio State University, Columbus, OH, USA; Department of Physiology and Cell Biology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA. Electronic a…
Förderung
- National Heart Lung and Blood Institute
- American Heart Association Inc
- National Center for Advancing Translational Sciences
Zitieren
APA
Gururaja Rao, S., Smith, A. R., & Singh, H. (2026). Repurposing triamterene to target CLIC1 in glioblastoma stem cells: A new opportunity for an old drug?. Molecular Therapy, 34(10), 5643-5645. https://doi.org/10.1016/j.ymthe.2026.09.010
Vancouver
Gururaja Rao S, Smith AR, Singh H. Repurposing triamterene to target CLIC1 in glioblastoma stem cells: A new opportunity for an old drug?. Molecular Therapy. 2026;34(10):5643-5645. doi:10.1016/j.ymthe.2026.09.010
BibTeX
@article{GururajaRao2026,
author = {Gururaja Rao, Shubha and Smith, Aviana R and Singh, Harpreet},
title = {Repurposing triamterene to target CLIC1 in glioblastoma stem cells: A new opportunity for an old drug?},
journal = {Molecular Therapy},
year = {2026},
volume = {34},
number = {10},
pages = {5643--5645},
doi = {10.1016/j.ymthe.2026.09.010}
}
EUVIMED